Pfizer-BioNTech COVID-19 Vaccine in Gynecologic Oncology Patients: A Prospective Cohort Study
Palaia, I.; Caruso, G.; Di Donato, V.; Vestri, A.; Napoli, A.; Perniola, G.; Casinelli, M.; Alunni Fegatelli, D.; Campagna, R.; Tomao, F.; D’Aniello, D.; Antonelli, G.; Muzii, L. Pfizer-BioNTech COVID-19 Vaccine in Gynecologic Oncology Patients: A Prospective Cohort Study. Vaccines 2022, 10, 12. https://doi.org/10.3390/vaccines10010012
Palaia I, Caruso G, Di Donato V, Vestri A, Napoli A, Perniola G, Casinelli M, Alunni Fegatelli D, Campagna R, Tomao F, D’Aniello D, Antonelli G, Muzii L. Pfizer-BioNTech COVID-19 Vaccine in Gynecologic Oncology Patients: A Prospective Cohort Study. Vaccines. 2022; 10(1):12. https://doi.org/10.3390/vaccines10010012
Chicago/Turabian StylePalaia, Innocenza, Giuseppe Caruso, Violante Di Donato, Annarita Vestri, Anna Napoli, Giorgia Perniola, Matteo Casinelli, Danilo Alunni Fegatelli, Roberta Campagna, Federica Tomao, Debora D’Aniello, Guido Antonelli, and Ludovico Muzii. 2022. "Pfizer-BioNTech COVID-19 Vaccine in Gynecologic Oncology Patients: A Prospective Cohort Study" Vaccines 10, no. 1: 12. https://doi.org/10.3390/vaccines10010012